42 U.S.C. § 300gg–120 — Reporting on pharmacy benefits and drug costs

(a) In general No later than 1 year after December 27, 2020, and by June 1 of every year after that, group health plans and issuers of group or individual coverage — except church plans — must report to the Secretary, the Secretary of Labor, and the Secretary of the Treasury a set of facts about the previous plan year: the plan year's start and end dates; the number of enrollees; every state where the plan or coverage is offered; the 50 brand-name prescription drugs dispensed most often, and the number of paid claims for each; the 50 costliest prescription drugs by total annual spending, and how much was spent on each; the 50 drugs whose plan spending grew the most compared with the prior plan year, and by how much; total health care spending broken down by hospital costs, provider and clinical-service costs (primary and specialty care shown separately), prescription drug costs, and other medical costs including wellness services, plus drug spending split between what the plan pays and what enrollees pay; the average monthly premium paid by employers and separately by enrollees; how rebates, fees, and other payments from drug manufacturers affect premiums, including amounts by therapeutic drug class and amounts for the 25 drugs that generated the most rebates; and any reduction in premiums or out-of-pocket costs tied to those rebates. (b) Report No later than 18 months after the first report under (a) is due, and every two years after that, the Secretary — acting through the Assistant Secretary for Planning and Evaluation and working with the HHS Inspector General — must publish a report on the internet about prescription drug reimbursement, drug pricing trends, and how drug costs affect premiums. The report must combine the data in a way that doesn't reveal information about any specific drug or plan. (c) Privacy protections Any confidential or trade-secret information submitted under (a) can't be included in the public report under (b).